Proteomics International Laboratories Ltd (ASX:PIQ)
0.3800
0.00 (0.00%)
May 2, 2025, 3:58 PM AEST
ASX:PIQ Revenue
Proteomics International Laboratories had revenue of 837.38K AUD in the half year ending December 31, 2024, with 9.16% growth. This brings the company's revenue in the last twelve months to 3.50M, up 15.29% year-over-year. In the fiscal year ending June 30, 2024, Proteomics International Laboratories had annual revenue of 3.28M with 2.99% growth.
Revenue (ttm)
3.50M
Revenue Growth
+15.29%
P/S Ratio
14.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
49.78M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 3.28M | 95.26K | 2.99% |
Jun 30, 2023 | 3.18M | -249.17K | -7.26% |
Jun 30, 2022 | 3.43M | 694.47K | 25.38% |
Jun 30, 2021 | 2.74M | 6.89K | 0.25% |
Jun 30, 2020 | 2.73M | 40.78K | 1.52% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Telix Pharmaceuticals | 783.21M |
Ramsay Health Care | 17.12B |
Ansell | 3.00B |
Mesoblast | 9.16M |